A third quality assured, generic DMPA-IM contraceptive product available for procurement
From Concept Foundation: July 2019
person
New beginnings @ConceptFNDN When I started working on the heat stable carbetocin project in 2012 at the Special Programme of Research on Human Reproduction (HRP), a public private partnership between WHO/HRP, Ferring Pharmaceuticals and MSD for Mothers I was surprised…
Read More Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial results released
person
folder_openFamily Planning
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial results have been released, finally providing long awaited answers to questions about the relationship between DMPA, the Implant and the Copper IUD and risk of HIV transmission in women.
Access to Quality Assured generic Intramuscular DMPA continues to rise
person
Access to Quality Assured generic Intramuscular DMPA continues to rise
New generic IM DMPA available for procurement
person
Mylan Laboratories Limited has received a risk category 1 ranking from the WHO Expert Review Panel for its generic injectable, medroxyprogesterone acetate depot 150mg/ml.
Generic implant receives positive ERP result
person
folder_openFamily Planning
The first generic two-rod sub-dermal levonorgestrel 75mg implant product has received a positive result from the Expert Review Panel (ERP), making it the first of its kind to reach the quality standard for international procurement.
The topmost drug technical advisory body of the Union Health Ministry in India has recommended the introduction of the injectable contraceptive DMPA
Concept Foundation is pleased to announce that India’s Drugs Technical Advisory Board recently agreed to the introduction of Depot-medroxyprogesterone acetate, or DMPA, under the National Family Planning Programme.
BMGF grant
The Bill & Melinda Gates Foundation awards Concept Foundation with a grant to continue and expand upon work initiated under QuRHM for DMPA.
News & Events
- WHO has just prequalified a combination mifepristone-misoprostol (combipack) for medical abortion
- WHO has just prequalified a combination mifepristone-misoprostol (combipack) for medical abortion
- A third quality assured, generic DMPA-IM product available for procurement
- From Concept Foundation: July 2019
- Concept Foundation announces A. Metin Gülmezoglu as its new Executive Director